E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/23/2008 in the Prospect News PIPE Daily.

New Issue: Medivation settles $15 million private placement of shares

By Devika Patel

Knoxville, Tenn., June 23 - Medivation, Inc. announced in an 8-K filed Monday with the Securities and Exchange Commission that it completed a $15 million private placement of stock on June 22.

The company sold 1,129,518 common shares at $13.28 per share.

San Francisco-based Medivation is a biopharmaceutical company that acquires technologies in the late preclinical development phase and develops them cost-effectively.

Issuer:Medivation, Inc.
Issue:Common stock
Amount:$15 million
Shares:1,129,518
Price:$13.28
Warrants:No
Settlement date:June 22
Stock symbol:Nasdaq: MDVN
Stock price:$12.77 at close June 20

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.